-
1 Comment
Antisense Therapeutics Limited is currently in a long term uptrend where the price is trading 21.3% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Antisense Therapeutics Limited's total revenue sank by 92.0% to $2K since the same quarter in the previous year.
Its net income has increased by 52.8% to $-2M since the same quarter in the previous year.
Finally, its free cash flow fell by 29.3% to $-926K since the same quarter in the previous year.
Based on the above factors, Antisense Therapeutics Limited gets an overall score of 3/5.
| Exchange | AU |
|---|---|
| CurrencyCode | AUD |
| ISIN | None |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Beta | nan |
|---|---|
| Dividend Yield | nan% |
| Market Cap | None |
| PE Ratio | nan |
| Target Price | nan |
Antisense Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals in Australia. Its product pipeline comprises ATL1102, an antisense inhibitor of CD49d, which is in Phase IIa clinical trial for the treatment of multiple sclerosis, Duchenne Muscular Dystrophy, asthma, and other inflammatory indications. The company's product pipeline also includes ATL1103, a second generation antisense drug designed to block growth hormone receptor expression thereby reducing levels of the hormone insulin-like growth factor-I in the blood, as well as to treat diseases associated with excessive growth hormone action that has completed Phase II clinical trial. Antisense Therapeutics Limited was incorporated in 2000 and is based in Toorak, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ANP.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
